Abstract
Children with mucopolysaccharidosis IIIA (MPS-IIIA) may receive a diagnosis of autism spectrum disorder (ASD) due to MPS-IIIA’s initial symptom similarities with ASD. This may lead to professionals receiving referrals to work with these children but unaware of how these children may respond differently to treatment. To appropriately work with these children, clinicians must obtain knowledge of the symptoms, progressions, regression, comorbidities, and clinical interventions. This manuscript guides clinicians on the discrimination of MPS-IIIA from ASD for (a) physiological symptoms, (b) skill development and regression of skills, and (c) behavior problems from infancy to adolescence. The manuscript also provides available intervention research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Baio, J., Wiggins, L., Christensen, D., Maenner, M., Daniels, J., Warren, Z., & Dowling, N. (2018). Prevalence of autism spectrum disorder among children aged 8 years – Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Morbidity and Mortality Weekly Report, 67(6), 1–23. https://doi.org/10.15585/mmwr.ss6706a1
Bax, M. C., & Colville, G. A. (1995). Behaviour in mucopolysaccharide disorders. Archives of Disease in Childhood, 73(1), 77–81.
Buhrman, D., Thakkar, K., Poe, M., & Escolar, M. L. (2014). Natural history of Sanfilippo syndrome type A. Journal of Inheritable Metabolic Disorders, 37, 431–437. https://doi.org/10.1007/s10545-013-9661-8
Cleary, M. A., & Wraith, J. E. (1993). Management of mucopolysaccharidosis type III. Archives of Disease in Childhood, 69(3), 403–406.
Cohen, D., Pichard, N., Tordjman, S., Baumann, C., Burglen, L., Excoffier, E., & Heron, D. (2005). Specific genetic disorders and autism: Clinical contribution towards their identification. Journal of Autism and Developmental Disorders, 35(1), 103–116. https://doi.org/10.1007/s10803-004-1038-2
Colville, G. A., & Bax, M. A. (1996). Early presentation in the mucopolysaccharide disorders. Child: Care Health and Development, 22(1), 31–36. https://doi.org/10.1111/j.1365-2214.1996.tb00420.x
Colville, G. A., Watters, J. P., Yale, W., & Bax, M. (1996). Sleep problems in children with Sanfilippo syndrome. Developmental Medicine and Child Neurology, 38(6), 538–544. https://doi.org/10.1111/j.1469-8749.1996.tb12114.x
Cross, E. M., & Hare, D. J. (2013). Behavioural phenotypes of the mucopolysaccharide disorders: A systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. Journal of Inherited Metabolic Disorders, 36, 189–200. https://doi.org/10.1007/s10545-012-9572-0
Delgadillo, V., O’Callaghan, M. D., Gort, L., Coll, M., & Pineda, M. M. (2013). Natural history of Sanfilippo syndrome in Spain. Orphanet Journal of Rare Diseases, 8, 189. https://doi.org/10.1186/1750-1172-8-189
Escolar, M. L., Jones, S. A., Shapiro, E. G., Horovitz, D. D., Lampe, C., & Amartino, H. (2017). Practical management of behavioral problems in mucopolysaccharidoses disorders. Molecular Genetics and Metabolism, 122(Suppl), 35–40. https://doi.org/10.1016/j.ymgme.2017.09.010
Fedele, A. O. (2015). Sanfilippo syndrome: Causes consequences and treatments. The Application of Clinical Genetics, 8, 269–281. https://doi.org/10.2147/TACG.S57672
Fraser, J., Gason, A. A., Wraith, J. E., & Delatycki, M. B. (2005). Sleep disturbance in Sanfilippo syndrome: A parental questionnaire study. Archives of Disease in Childhood, 90(12), 1239–1242. https://doi.org/10.1136/adc.2004.065482
Fraser, J., Wraith, J. E., & Delatycki, M. B. (2002). Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): A survey of managing clinicians. Clinical Genetics, 62, 418–421. https://doi.org/10.1034/j.1399-0004.2002.620512.x
Guerrero, J. M., Pozo, D., Diaz-Rodriguez, J. L., Martinez-Cruz, F., & Vela-Campos, F. (2006). Impairment of the melatonin rhythm in children with Sanfilippo syndrome. Journal of Pineal Research, 40(2), 192–193. https://doi.org/10.1111/j.1600-079X.2005.00294.x
Ghosh, A., Shapiro, E., Rust, S., Delaney, K., Parker, S., Shaywitz, A., Morte, A., Bubb, G., Cleary, M., Bo, T., Lavery, C., Bigger, B. W., & Jones, S. A. (2017). Recommendations on clinical trial design for treatment of mucopolysaccharidosis type III. Orphanet Journal of Rare Diseases, 12, 1–15. https://doi.org/10.1186/s13023-017-0675-4
Grant, N. (2021). Evaluating strategies to manage and endure challenging behavior in mucopolysaccharidoses. Orphanet Journal of Rare Diseases, 16, 1–5. https://doi.org/10.1186/s13023-021-01767-8
Heron, B., Mikaeloff, Y., Froissart, R., Caridade, G., Maire, I., Caillaud, C., & Tardieu, M. (2010). Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. American Journal of Medical Genetics Part A, 155(1), 58–68. https://doi.org/10.1002/ajmg.a.33779
Hoffman, F., Hoffman, S., Kunzmann, K., & Reis, M. (2020). Challenging behavior in mucopolysaccharidoses types 1-III and day-today coping strategies: A cross sectional explorative study. Orphanet Journal of Rare Diseases, 15, 275. https://doi.org/10.1186/s13023-020-01548-9
Mahon, L. V., Lomax, M., Grant, S., Cross, E., Hare, D. J., Wraith, J. E., & Canal, M. (2014). Assessment of sleep in children with mucopolysaccharidosis type III. PloS One, 9(2), e84128. https://doi.org/10.1371/journal.pone.0084128
Malcolm, C., Hain, R., Gibson, F., Adams, S., Anderson, G., & Forbat, L. (2012). Challenging symptoms in children with rare life-limiting conditions: Findings from a prospective diary and interview study with families. Acta Paediatrica, 101, 985–992. https://doi.org/10.1111/j.1651-2227.2012.026780.x
Malm, G., & Mansson, J. E. (2010). Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: Clinical presentation of 22 children diagnosed during a 30-year period. Acta Paediatrica, 99(8), 1253–1257. https://doi.org/10.1111/j.1651-2227.2010.01800.x
Mariotti, P., Marca, G. D., Iuvone, L., Vernacotola, S., Ricci, R., Mennuni, G. F., & Mazza, S. (2003). Sleep disorders in Sanfilippo syndrome: A polygraphic study. Clinical Electroencephalography, 34(1), 18–22. https://doi.org/10.1177/155005940303400108
Matson, J. L., Belva, B., Hattier, M. A., & Matson, M. L. (2011). Pica in persons with developmental disabilities: Characteristics, diagnosis, and assessment. Research in Autism Spectrum Disorders, 5(4), 1459–1464. https://doi.org/10.1016/j.rasd.2011.02.006
Meyer, A., Kossow, K., Gal, A., Muhlhausen, C., Braulke, T., & Muschol, N. (2007). Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics, 120, 1255–1261. https://doi.org/10.1542/peds.2007-0282
Milnes, S. M., & Piazza, C. C. (2013). Intensive treatment of pediatric feeding disorders. In D. Reed, F. DiGennaro Reed, & J. Luiselli (Eds.), Handbook of crisis intervention and developmental disabilities. Issues in Clinical Child Psychology (pp. 393–408). Springer
Moss, J., & Howlin, P. (2009). Autism spectrum disorders in genetic syndromes: Implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. Journal of Intellectual Disability Research, 53, 852–873. https://doi.org/10.1111/j.1365-2788.2009.01197.x
Napolitano, D. A., Jack, S. L., Sheldon, J. B., Williams, D. C., McAdam, D. B., & Schroeder, S. R. (1999). Drug-behavior interactions in persons with mental retardation and developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 5, 322–334. https://doi.org/10.1002/(SICI)1098-2779(1999)5:4%3c322::AID-MRDD10%3e3.3.CO;2-6
National Autism Center. (2009). The National Autism Center’s national standards report. Randolph, MA: National Autism Center
National Autism Center. (2015). The National Autism Center’s national standards report: Findings and conclusions, phase 2. Randolph, MA: National Autism Center.
Nidiffer, F. D., & Kelly, T. E. (1983). Developmental and degenerative patterns associated with cognitive, behavioral and motor difficulties in the Sanfilippo syndrome: An epidemiological study. Journal of Mental Deficiency Research, 27, 185–203. https://doi.org/10.1111/j.1365-2788.1983.tb00291.x
Ozonoff, S., Williams, B. J., & Landa, R. (2005). Parental report of the early development of children with regressive autism: The delays-plus-regression phenotype. Autism, 9, 461–486. https://doi.org/10.1177/136236105057880
Porter, K. A., O’Neill, C., Drake, E., Parker, S., Escolar, M. L., Montgomery, S., Moon, W., Worrall, C., & Peay, H. L. (2020). Parent experiences of Sanfilippo syndrome impact and unmet treatment needs: A qualitative assessment. Neural Therapy Online. https://doi.org/10.1007/s40120-0200-00226-z
Rumsey, R. K., Rudser, K., Delaney, K., Potegal, M., Whitley, C. B., & Shapiro, E. (2014). Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA. The Journal of Pediatrics, 164(5), 1147-1151. https://doi.org/10.1016/j.jpeds.2014.01.007
Schreck, K. A., Helsel, C., Paxon, A., Weston, K., & Daniels, M. (2018). Regression trends & treatment effectiveness to improve quality of life for a pre-adolescent girl with MPS IIIA. Journal of Developmental Disabilities, 30, 545–558. https://doi.org/10.1007/s10882.018.9601.5
Shapiro, E., Ahmend, A., Whiteley, C., & Delaney, K. (2018). Observing the advanced disease course in mucopolysaccharidosis, type IIIA; a case series. Molecular Genetics and Metabolism, 123(2), 123–126. https://doi.org/10.1016/j.ymgme.2017.11.014
Shapiro, E. G., & Eisengart, J. B. (2021). The natural history of neurocognition in MPS disorders: A review. Molecular Genetics and Metabolism, 133, 8–34. https://doi.org/10.1016/j.ymgme.2021.03.002
Shapiro, E. G., Nestrasil, I., Ahmed, A., Wey, A., Rudser, K. R., Haslett, P. A., & Potegal, M. (2015). Quantifying behaviors of children with Sanfilippo syndrome: The Sanfilippo behavior rating scale. Molecular genetics and metabolism, 114(4), 594–598. https://doi.org/10.1016/j.ymgme.2015.02.008
Shapiro, E. G., Nestrasil, I., Delaney, K. A., Rudser, K., Kovac, V., Nair, N., & Whitley, C. B. (2016). A prospective natural history study of mucopolysaccharidosis type IIIA. The Journal of Pediatrics, 170, 278–287. https://doi.org/10.1016/j.peds.2015.11.079
Sorrentino, N. C., & Fraldi, A. (2016). Brain targeting in MPS-IIIA. Pediatric Endocrinology Reviews, 13(Suppl 1), 630–638.
Sprague, R. L., & Werry, J. S. (1971). Methodology of psychopharmacological studies with the retarded. In N. R. Ellis (Ed.). International Review of Research in Mental Retardation (Vol 5, pp. 147–219). Academic Press
Stapleton, M., Hoshina, H., Sawamoto, K., Kubaski, F., Mason, R. W., Mackenzie, W. G., & Tomatsu, S. (2019). Critical review of current MPS guidelines and management. Molecular Genetics and Metabolism, 126(3), 238–245. https://doi.org/10.1016/j.ymgme.2018.07.001
Truxal, K. V., Fu, H., McCarty, D. M., McNally, K. A., Kunkler, K. L., Zumberge, N. A., Martin, L., Aylward, S. C., Alfano, L. N., Berry, K. M., Lowes, L. P., Corridore, M., McKee, C., McBride, K. L., & Flanigan, K. M. (2016). A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design. Molecular Genetics and Metabolism, 119, 239–248. https://doi.org/10.1016/j.ymgme.2016.08.002
Valstar, M. J., Marchal, J. P., Grootenhuis, M., Colland, V., & Wijburg, F. A. (2011). Cognitive development in patients with mucopolysaccharidosis type III (Sanfilippo syndrome). Journal of Rare Diseases, 6, 43-43. https://doi.org/10.1186/1750-1172-6-43
Valstar, M. J., Neijs, S., Bruggenwirth, H. T., Olmer, R., Ruitjer, G. J., Wevers, R. A., & Wijburg, F. A. (2010). Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype-phenotype correlations. Annals of Neurology, 68(6), 876–887. https://doi.org/10.1002/ana.22092
Valstar, M. J., Ruijter, J. G., van Diggelen, O. P., Poorthius, B. J., & Wijburg, F. A. (2008). Sanfilippo syndrome: A mini-review. Journal of Inheritable Metabolic Diseases, 31, 240–252. https://doi.org/10.1007/s10545-008-0838-5
van De Kamp, J. J., Niermeijer, M. F., Von Figura, K., & Giesberts, M. A. (1981). Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clinical Genetics, 20, 152–160. https://doi.org/10.1111/j.1399-0004.1981.tb01821.x
Wijburg, F. A., Wegrzyn, G., Burton, B. K., & Tylki-Szymanska, A. (2013). Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Acta Paediatrica, 102, 462–470. https://doi.org/10.1111/apa.12169
Williams, D. E., & McAdam, D. (2012). Assessment, behavioral treatment, and prevention of pica: Clinical guidelines and recommendations for practitioners. Research in Developmental Disabilities, 33(6), 2050–2057. https://doi.org/10.1016/j.ridd.2012.04.001
Wolfenden, C., Wittkowski, A., & Hare, D. J. (2017). Symptoms of autism spectrum disorder (ASD) in individuals with mucopolysaccharide disease type III (Sanfilippo syndrome): A systematic review. Journal of Autism and Developmental Disorders, 47, 3620–3633. https://doi.org/10.1007/s10803-017-3262-6
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Research Ethics and Consent
N/A.
Employment
Kimberly A. Schreck was and remains a faculty member at the Penn State Harrisburg. Lindsay Kluth was a graduate student at time of paper completion and is currently employed with the Merakey Autism School.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schreck, K.A., Knapp, L.M. MPS-IIIA or Autism Spectrum Disorder?: Discrimination and Treatment. Rev J Autism Dev Disord 10, 383–390 (2023). https://doi.org/10.1007/s40489-021-00298-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40489-021-00298-z